Great work from Aga and Mélanie Tichet. Congrats! cell.com/cancer-cell/fu…

The Bod lab opened its doors today! We will be dissecting the role of B(est) cells in cancer. Recruitments will start soon, please reach out if interested! I cannot wait to not be alone in the lab 🥳 Mass General Cancer Center Harvard Medical School Broad Institute

Great 1st symposium by yEFIS! Strongly suggest all young (or not so young 😉) europeen immunologists to attend the next meeting! #yefis2022

Happy to share our paper in Immunity on combining PD1-IL2v and anti-PD-L1 to enable anti-tumor immunity in immunotherapy-resistant cancers. Thanks to Stephan Wullschleger, Aga, #DougHanahan & our collaborators SIB, Oncology UNIL CHUV Roche. cell.com/immunity/fullt…

Join us on 09 March for our next 'Meet the Author'webinar with Prof. Douglas Hanahan and Adnieszka Chryplewicz who will be discussing their most recent paper. Registration is FREE for EACR members: ➡️ ow.ly/rEYp50N1QKf

IFNγ-induced stem-like state of cancer cells as a driver of metastatic progression following immunotherapy dlvr.it/Sq3tC3

Thanks to Kevin Roarty for this nice preview of our work published in Cell Stem Cell Cell Press!!!

Researcher Laurent Beziaud at EPFL Life Sciences focused on the role of cancer stem cell (CSC) plasticity in immune evasion following ICB. In mouse breast tumor models, T cell-produced IFNγ increased conversion of non-CSCs to CSCs, which increased chemo- and [...] bit.ly/3J2U5GN

The Chapter I of my postdoc journey at @kuchroolab is now online! Beyond our findings, it's been an incredible human experience. We describe a B-cell state expressing checkpoint molecules uncovering Tim-1, as a potent regulator of anti-tumor immunity: nature.com/articles/s4158…. 1/5

IFNγ-induced stem-like state of cancer cells as a driver of metastatic progression following immunotherapy by Laurent Beziaud et al. High-quality paper handpicked by the Cell Stem Cell editorial team hubs.li/Q026w_PF0

I am excited to share that I am starting my lab at the Georg-Speyer-Haus Institute in Frankfurt! linkedin.com/posts/m%C3%A9l…

Great opportunity for a PhD or a postdoc in the lab of the top scientist Mélanie Tichet, on the study of the tumor microenvironment and the development of anti-cancer therapy!

🎉👏Welcome Mélanie Tichet, our newly established FCI group leader #Tumorimmunology. Mélanie & her lab investigate #immunoregulatory mechanisms in the #tumormicroenvironment and resistance to therapy. More➡️georg-speyer-haus.de/en/staff/tiche…